Moderna to ask U.S., Europe to allow emergency use of its COVID-19 vaccine

Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine.

This comes as the Massachusetts company released results from its new study.

It says of 196 COVID-19 cases so far in its huge U.S. study, only 11 were trial participants who received the real vaccine.

Thirty people got severely ill and all of them got the placebo.

Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December.